Clinical Services from the Name You Know and Trust
Clinical Services
Our clinical lab is CLIA certified by The Centers for Medicare & Medicaid Services (CMS) and accredited by the College of American Pathologists (CAP) for clinical NGS. Routine inspections are performed on our clinical lab by CAP for accreditation renewal. Our commitment to providing reliable, cost-effective services and high-quality results remains paramount for our clinical service portfolio. We offer regulatory compliance, flexible QA oversight levels, and documentation to support a wide range of client regulatory requirements, from RUO to complete CLIA validations. We treat all customer information, study-related data, and intellectual property with the same degree of care and security that we do for our own. This allows our customers at both top-tier pharmaceutical companies and biotechnology start-ups the flexibility to utilize our regulatory services while trusting in our commitment to quality and communication.
REGULATED ASSAYS
Biospecimens are processed in our CLIA-certified, CAP-accredited laboratory by CLIA-trained personnel on CLIA-qualified equipment. Our clinical lab offers flexibility in documentation and QA oversite depending on client needs. This offering is ideal for biomarker discovery, monitoring, and exploratory endpoints.
Genomics
- Whole Genome Sequencing (WGS)
- Low-Pass WGS
- Whole Exome Sequencing (WES)
- Targeted Panels
- Amplicon Sequencing
- Metagenomics
- Genotyping
Transcriptomics
- Whole Transcriptome Sequencing
- mRNA Sequencing
- Small RNA Sequencing
- Immuno-Profiling
- RT-qPCR
Epigenomics
- Whole Genome Methylation Sequencing
- Targeted Methylation Sequencing
- Olink® Target Panels
- Olink® Explore Panels
- Digital Spatial Profiling
Proteomics
Clinical Workflows
Customizable workflows specifically engineered to maximize quality results for difficult samples types.
CLIA Fit-For-purpose Validations
We offer fit-for-purpose CLIA assay validations for any of our CLIA environment offerings, client-specific assays, or custom assay development. Validations can include test registration if applicable for client studies. Recommended if data is used for diagnostic purposes.
Assay Development
CLIA & CAP Validation
Test Registration
Features & Benefits
Technical Resources
Tech Note | High-Fidelity Production of In In Vitro Plasmids with Long Poly(A) Sequences
Poly(A) tail sequences can impact the integrity of your mRNA plasmids for in vitro
transcription. While longer poly(A) tails have been shown to increase their stability, tails
greater than 100 bases are susceptible to truncations. Learn how the proprietary mRNA plasmid
preparation protocol from Azenta can help you generate higher yields and preserve poly(A) tails
of greater lengths compared to standard protocols for high-fidelity templates in our tech note.
